Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

101.10
+0.79000.79%
Volume:42.81K
Turnover:4.29M
Market Cap:24.26B
PE:-35.25
High:101.10
Open:100.08
Low:99.92
Close:100.31
Loading ...

Biontech Completes Acquisition Of Biotheus

Reuters
·
03 Feb

Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability

GlobeNewswire
·
03 Feb

Warburg Research Sticks to Its Buy Rating for AMADEUS FIRE (0DK9)

TIPRANKS
·
03 Feb

Andreas Halvorsen Reduces Stake in BridgeBio Pharma Inc

GuruFocus
·
01 Feb

Admiral Group downgraded to Reduce from Hold at Peel Hunt

TIPRANKS
·
31 Jan

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19

Business Wire
·
31 Jan

Deutsche Bank AG (DB) Receives a Buy from Warburg Research

TIPRANKS
·
30 Jan

What Has RFK Jr. Said About Covid-19?

Dow Jones
·
29 Jan

Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability

NewMediaWire
·
29 Jan

Is Pfizer Inc. (PFE) the Safe Stock to Buy for the Long Term in 2025?

Insider Monkey
·
29 Jan

Deutsche Boerse (0H3T) Gets a Buy from Warburg Research

TIPRANKS
·
28 Jan

Warburg Research Sticks to Their Hold Rating for SAP SE (0NW4)

TIPRANKS
·
28 Jan

BioNTech SE (BNTX) Receives a Hold from J.P. Morgan

TIPRANKS
·
27 Jan

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide

NewMediaWire
·
27 Jan

Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA’s Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromised Patients

GlobeNewswire
·
27 Jan

Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19

GlobeNewswire
·
27 Jan